Halma has snapped up California-based ophthalmic instruments maker Surgistar for $90m (circa £67m) in cash, adding it as a bolt-on to its existing healthcare subsidiary MicroSurgical Technology (MST).
Surgistar, which has been operating for more than 20 years, designs and manufactures surgical blades, cannulas and trephines used in eye surgery. The company’s highly automated production processes are a key part of its appeal, delivering consistent quality at scale, a natural complement to MST’s existing capabilities.
The deal, funded by Halma’s existing facilities, is part of the group’s strategy to build out its healthcare sector through targeted, complementary acquisitions.
Marc Ronchetti, Group Chief Executive of Halma, said: “Surgistar’s differentiated product range is highly complementary to MST’s and further strengthens Halma’s ophthalmic product offering. The acquisition enhances MST’s manufacturing capabilities and supports its long-term growth through MST’s existing direct and global channels. We are excited to see our existing companies expand their capabilities through bolt-on acquisitions and delighted to welcome Surgistar to Halma.”
Halma has long grown through acquisitions, making seven acquisitions in 2024/25, down from eight in 2023/2024.